Abstract:Tanshinone I, one of the components of Salvia miltiorrhiza Bunge, exhibits anti-tumor ability and induces autophagy. But the mechanisms are not fully understood. This study aims to investigate whether AMP-activated protein kinase dependent pathway is involved in the autophagic signaling regulation and its relationship with tumor suppression. Breast cancer cells (MDA-MB-231, MCF-7) and hepatocellular carcinoma cells (HepG2) were treated with Tanshinone I or vehicle. Acridine orange dyeing and transmission electron microscopy were employed to evaluate autophagic cells. MTT and Cell Counting Kit-8 assays were used to detect the effect of Tanshinone I combined with autophagy inhibitors on cell proliferation. Western blot was used to detect the expression levels of Beclin1 and LC3-I/II, as well as the phosphorylation of AMPK alpha and ULK1. Our results showed that Tanshinone I suppressed proliferation of HepG2, MDA-MB-231 and MCF-7 cancer cell lines. LC3-II and P62 were induced by Tanshinone I in all three cancer cell lines. But autophagic flux analysis showed that Tanshinone I treatment induced autophagy only in MDA-MB-231, which was also proved by transmission electron microscopy. Tanshinone I upregulated the phosphorylation of AMPK alpha and its downstream ULK1. AMP-activated protein kinase inhibitor compound C attenuated Beclin 1 and LC3-II expression induced by Tanshinone I in HepG2. In MDA-MB-231, compound C surprisingly induced LC3-II upregulation which is independent of AMPK alpha activation. Under this circumstance, treatment of Tanshinone I combined with compound C significantly inhibited MDA-MB-231 proliferation, compared with Tanshinone I treatment alone. This study demonstrates that Tanshinone I could induce cancer cell death and regulate autophagy signaling in breast cancer and hepatic carcinoma cells. Activation of AMPK alpha was found to be involved in autophagic signaling regulation by Tanshinone I.

Tubeimoside I Induces Autophagy in HepG2 Cells by Activating the AMP-activated Protein Kinase Signaling Pathway

Tubeimoside-1, a triterpenoid saponin, induces cytoprotective autophagy in human breast cancer cells in vitro via Akt-mediated pathway

Tubeimoside I induces accumulation of impaired autophagolysosome against cervical cancer cells by both initiating autophagy and inhibiting lysosomal function

Natural plant extract tubeimoside I induces cytotoxicity via the mitochondrial pathway in human normal liver cells.

Tubeimoside I Inhibits Cell Proliferation and Induces a Partly Disrupted and Cytoprotective Autophagy Through Rapidly Hyperactivation of MEK1/2-ERK1/2 Cascade via Promoting PTP1B in Melanoma

Natural Plant Extract Tubeimoside I Promotes Apoptosis-Mediated Cell Death in Cultured Human Hepatoma (hepg2) Cells.

Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway.

Tubeimoside-I sensitizes colorectal cancer cells to chemotherapy by inducing ROS-mediated impaired autophagolysosomes accumulation

Tubeimoside-2 Triggers Methuosis in Hepatocarcinoma Cells through the MKK4–p38α Axis

The Potential Role of Tubeimosides in Cancer Prevention and Treatment

Tubeimoside I-induced lung cancer cell death and the underlying crosstalk between lysosomes and mitochondria

Effects Of Tubeimoside-1 On The Proliferation And Apoptosis Of Bgc823 Gastric Cancer Cells In Vitro

Cytotoxicity of Tubeimoside I in Human Choriocarcinoma JEG-3 Cells by Induction of Cytochrome C Release and Apoptosis Via the Mitochondrial-Related Signaling Pathway.

Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR

Unraveling the Action Mechanism of Tubeimoside-1 against Tumor Microvessels via Network Pharmacology and Experimental Validation

Tanshinone I regulates autophagic signaling via the activation of AMP-activated protein kinase in cancer cells.

TBMS1 Exerts Its Cytotoxicity in NCI-H460 Lungcancer Cells Through Nucleolar Stress-Induced P53/mdm2-Dependent Mechanism, a Quantitativeproteomics Study

Tubeimoside-1: A review of its antitumor effects, pharmacokinetics, toxicity, and targeting preparations

In Vitro Assay of Cytoskeleton Nanomechanics As A Tool for Screening Potential Anticancer Effects of Natural Plant Extract, Tubeimoside I on Human Hepatoma (hepg2) Cells

Multiple Pathways Were Involved in Tubeimoside-1-induced Cytotoxicity of HeLa Cells.

Tubeimoside-I, an inhibitor of HSPD1, enhances cytotoxicity of oxaliplatin by activating ER stress and MAPK signaling pathways in colorectal cancer